These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4618519)

  • 1. The effect of cell dose and distribution on the development of a transplanted tumour.
    Woodruff MF; Dunbar N
    Eur J Cancer (1965); 1974 Aug; 10(8):533-7. PubMed ID: 4618519
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preferential efficicacy of immunocomplexes in the facilitation of tumor allografts].
    Duc HT; Kinsky RG; Voisin GA
    Ann Immunol (Paris); 1973 Nov; 124(4):567-72. PubMed ID: 4134880
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of C. parvum on the number and activity of macrophages in primary and transplanted murine fibrosarcomas.
    McBride WH; Woodruff MF; Forbes GM; Moore K
    Br J Cancer; 1982 Sep; 46(3):448-51. PubMed ID: 7126431
    [No Abstract]   [Full Text] [Related]  

  • 4. Concomitant immunity to syngeneic methylcholanthrene-induced tumours in mice. Occurrence and specificity of concomitant immunity.
    Kearney R; Nelson DS
    Aust J Exp Biol Med Sci; 1973 Dec; 51(6):723-35. PubMed ID: 4788454
    [No Abstract]   [Full Text] [Related]  

  • 5. Macrophage content of tumours in relation to metastatic spread and host immune reaction.
    Eccles SA; Alexander P
    Nature; 1974 Aug; 250(5468):667-9. PubMed ID: 4546859
    [No Abstract]   [Full Text] [Related]  

  • 6. T lymphocyte requirement for MSV tumour prevention or regression.
    Collavo D; Colombatti A; Chieco-Bianchi L
    Nature; 1974 May; 249(453):169-70. PubMed ID: 4545519
    [No Abstract]   [Full Text] [Related]  

  • 7. Further studies on the effect of a transplanted methylcholanthrene-induced fibrosarcoma on humoral immunity in CBA mice.
    James K; Milne I; Warr G
    Clin Exp Immunol; 1974 Oct; 18(2):243-50. PubMed ID: 4468197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Pasteurella pneumotropica on the growth of transplanted Walker sarcoma cells.
    Simpson W; Simmons DJ; Davies AJ
    Br J Cancer; 1980 Sep; 42(3):473-76. PubMed ID: 6968573
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro activity of subpopulations of immune lymphocytes against murine sarcoma cells.
    Lamon EW; Wigzell H
    Transplantation; 1974 Oct; 18(4):368-71. PubMed ID: 4547517
    [No Abstract]   [Full Text] [Related]  

  • 10. The development and specific suppression of concomitant immunity in two syngeneic tumour-host systems.
    Chandradasa KD
    Int J Cancer; 1973 May; 11(3):648-62. PubMed ID: 4598551
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunodepression as a factor during 3-methylcholanthrene carcinogenesis and subsequent tumour growth in mice.
    Rees JA; Symes MO
    Int J Cancer; 1973 Jan; 11(1):202-11. PubMed ID: 4151450
    [No Abstract]   [Full Text] [Related]  

  • 12. Specificity of T cell responses to murine chemically-induced tumor antigens.
    Perry LL; Ziegler HK; Brunner B
    Prog Clin Biol Res; 1987; 244():147-57. PubMed ID: 3309997
    [No Abstract]   [Full Text] [Related]  

  • 13. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). II. Detection of cell-surface antigens by indirect membrane immunofluorescence.
    Jones DB; Moore M
    Br J Cancer; 1974 Feb; 29(2):158-67. PubMed ID: 4133783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific T cell-dependent, antigen-antibody mediated suppression of macrophages: abrogation by nonspecifically stimulated T cells.
    Rao VS; Mokyr MB; Gershon RK; Mitchell MS
    J Immunol; 1977 Jun; 118(6):2117-24. PubMed ID: 325141
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of immunosuppression on the induction and immunogenicity of chemically induced sarcomas.
    Fisher JC; Davis RC; Mannick JA
    Surgery; 1970 Jul; 68(1):150-6; discussion 156-7. PubMed ID: 10483462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking of syngeneic effector T cells by soluble tumour antigens.
    Plata F; Levy JP
    Nature; 1974 May; 249(454):271-4. PubMed ID: 4545403
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence for non-identity of T killer and T helper cells sensitised to allogeneic cell antigens.
    Dennert G
    Nature; 1974 May; 249(455):358-60. PubMed ID: 4135312
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of local injection of Corynebacterium parvum on the growth of a murine fibrosarcoma.
    Woodruff MF; Dunbar N
    Br J Cancer; 1975 Jul; 32(1):34-41. PubMed ID: 1080671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific immunoprotection with 3 M KCl solubilized tumor antigen.
    Kahan BD; Pellis NR
    J Surg Res; 1975 Mar; 18(3):263-9. PubMed ID: 1134089
    [No Abstract]   [Full Text] [Related]  

  • 20. Host immunity to a growing transplanted methylcholanthrene-induced guinea pig sarcoma.
    Cohen AM; Millar RC; Ketcham AS
    Cancer Res; 1972 Nov; 32(11):2421-6. PubMed ID: 5082590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.